Amy J. Jones

发表

Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery

V. Avery, B. Sleebs, Sandra Duffy, 2017, Antimicrobial Agents and Chemotherapy.

Synthesis and evaluation of phenoxymethylbenzamide analogues as anti-trypanosomal agents

J. Baell, R. Payne, Alexandra Manos-Turvey, 2015 .

3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.

J. Baell, V. Avery, S. Charman, 2013, European journal of medicinal chemistry.

Whole-organism high-throughput screening against Trypanosoma brucei brucei

V. Avery, Amy J. Jones, 2013, Expert opinion on drug discovery.

Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway

K. Saliba, V. Avery, J. Holleran, 2016, Parasites & Vectors.

Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.

Christel A. S. Bergström, J. Baell, V. Avery, 2014, Journal of medicinal chemistry.

Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides.

Ana Rodriguez, K. Read, J. Baell, 2016, Journal of medicinal chemistry.

Facile Synthesis and Preliminary Structure-Activity Analysis of New Sulfonamides Against Trypanosoma brucei.

J. Baell, V. Avery, Adel A Rashad, 2014, ACS medicinal chemistry letters.

Melarsoprol cyclodextrin inclusion complexes for the treatment for human African trypanosomiasis

Amy J. Jones, 2011 .

Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide

K. Read, J. Baell, M. McConville, 2016, Metabolomics.

Screening a Natural Product-Based Library against Kinetoplastid Parasites

V. Avery, Rohan A. Davis, T. Shelper, 2017, Molecules.

Trypanocidal Activity of Marine Natural Products

V. Avery, T. Grkovic, M. Sykes, 2013, Marine drugs.

Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness.

J. Baell, V. Avery, P. Keller, 2020, RSC medicinal chemistry.

Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis

V. Avery, M. Kaiser, Amy J. Jones, 2015, Antimicrobial Agents and Chemotherapy.

Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway

K. Saliba, V. Avery, J. Holleran, 2016, Parasites & Vectors.

6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.

J. Baell, V. Avery, S. Charman, 2015, Journal of medicinal chemistry.

Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

Jessica A. Engel, D. Fairlie, Susanna S. Ng, 2015, International journal for parasitology. Drugs and drug resistance.

Future treatment options for human African trypanosomiasis

V. Avery, Amy J. Jones, 2015, Expert review of anti-infective therapy.

Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity

M. Cooper, V. Avery, N. West, 2018, Journal of medicinal chemistry.

Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis

George Gettinby, Michael P. Barrett, Barbara Bradley, 2011, PLoS neglected tropical diseases.

Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.

C. Nelson, M. Sadowski, V. Avery, 2015, Journal of natural products.

Discovery of Potent N-Ethylurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi.

Ana Rodriguez, J. Baell, V. Avery, 2019, ACS medicinal chemistry letters.

6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.

J. Baell, V. Avery, S. Charman, 2015, Journal of medicinal chemistry.